You just read:

ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV

News provided by

ViiV Healthcare

May 26, 2015, 09:00 ET